Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Nephron. Experimental Nephrology|October 2, 2003
Role of Fcgamma receptors in glomerulonephritisRuth M Tarzi, H Terence CookTherapeutics and Clinical Risk Management|May 3, 2014
Current and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis)Ruth M Tarzi, Charles D PuseySeminars in Nephrology|August 16, 2011
Crescentic glomerulonephritis: new aspects of pathogenesisRuth M Tarzi, H Terence Cook, Charles D PuseyNature Reviews. Rheumatology|May 7, 2014
Issues in trial design for ANCA-associated and large-vessel vasculitisRuth M Tarzi, Justin C Mason, Charles D PuseyPeritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|April 21, 2006
Fluorodeoxyglucose positron emission tomography detects the inflammatory phase of sclerosing peritonitisRuth M Tarzi, John W Frank, Sohail Ahmad, et al.The American Journal of Pathology|January 27, 2004
Leptin-deficient mice are protected from accelerated nephrotoxic nephritisRuth M Tarzi, H Terence Cook, Ian Jackson, et al.The American Journal of Pathology|April 23, 2003
Both Fcgamma receptor I and Fcgamma receptor III mediate disease in accelerated nephrotoxic nephritisRuth M Tarzi, Kevin A Davies, Jill W C Claassens, et al.Clinical Journal of the American Society of Nephrology : CJASN|August 1, 2008
Assessing the validity of an abdominal CT scoring system in the diagnosis of encapsulating peritoneal sclerosisRuth M Tarzi, Adrian Lim, Steven Moser, et al.Kidney International|November 13, 2002
Nephrotoxic nephritis is mediated by Fcgamma receptors on circulating leukocytes and not intrinsic renal cellsRuth M Tarzi, Kevin A Davies, Michael G Robson, et al.European Journal of Clinical Investigation|August 11, 2010
CCL18 in peritoneal dialysis patients and encapsulating peritoneal sclerosisSohail Ahmad, Bernard V North, Ashfaq Qureshi, et al.Pageof 2